Related Experiment Video
Updated: Apr 19, 2026
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
Closing the gap: accelerating the translational process in nanomedicine by proposing standardized characterization
Ali A Khorasani1, James L Weaver2, Carolina Salvador-Morales3
1Department of Chemistry and Biochemistry, George Mason University, Fairfax, VA, USA ; Bioengineering Department, George Mason University, Fairfax, VA, USA ; Krasnow Institute for Advanced Study, George Mason University, Fairfax, VA, USA.
Standardizing nanomaterial characterization and understanding their interactions with proteins are crucial for advancing nanomedicine. This research proposes universal standards to accelerate clinical translation of novel nanomaterials for disease treatment.
Area of Science:
- Nanomedicine
- Materials Science
- Biotechnology
Background:
- Significant investment in nanomedicine research aims to develop novel disease treatments.
- Nanomaterials exhibit unique properties advantageous for medical applications at the bench level.
- Clinical translation of nanomedicine is hindered by a lack of universal characterization standards and incomplete understanding of nanomaterial-protein interactions.
Purpose of the Study:
- To review recent advancements in nanomaterial characterization techniques.
- To present current knowledge on nanomaterial interactions with proteins in the human body.
- To propose a standardized approach for nanomaterial characterization and address regulatory considerations for clinical translation.
Main Methods:
- Comprehensive literature review on nanomaterial characterization.
- Analysis of existing data on nanomaterial-protein interactions.
- Proposal of a standard set of techniques for universal nanomaterial characterization.
- Discussion of regulatory pathways for nanomedicine development.
Main Results:
- Identified critical limitations in current nanomaterial characterization methods.
- Summarized key findings on the complex interactions between nanomaterials and biological proteins.
- Proposed a framework for standardized nanomaterial characterization.
- Highlighted regulatory challenges in the translation of nanomedicine.
Conclusions:
- Establishing universal standards for nanomaterial characterization is essential.
- A deeper understanding of nanomaterial-protein interactions will facilitate nanomedicine development.
- Adoption of standardized characterization and improved biological interaction knowledge will accelerate the clinical application of nanomedicine.
More Related Videos
06:57Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
Published on: August 11, 2018
08:52Improving Reproducibility to Meet Minimal Information for Studies of Extracellular Vesicles 2018 Guidelines in Nanoparticle Tracking Analysis
Published on: November 17, 2021